Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Pharmacokinetics of nicotine carbomer enema evaluated in UC patients and volunteers

July 16, 1997

Dainippon presents promising antisecretory agent

July 15, 1997

BMS compound excellent candidate for development in HBV

July 14, 1997

Antiulcer drug shows bactericidal activity against H. pylori

July 14, 1997

Losec available in U.K. for symptoms of dyspepsia

July 9, 1997

Novopharm granted final approval by U.S. Federal Court to market generic Zantac

July 7, 1997

Genzyme and Massachusetts General Hospital to collaborate on gene therapy projects

July 1, 1997

Endothelin antagonist protects against indomethacin-induced gastric damage

July 1, 1997

Seikagaku's SOD preparation enters clinic in Europe

June 27, 1997

Abbott selects new motilide as candidate for GI motility disorders

June 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...